Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions

References

• Lachowsky M, Nappi RE. The effects of oestrogen on urogenital health. Maturitas 2009;63:149–51
   PubMed Web of Science ®Google Scholar
• Bruce D, Rymer J. Symptoms of the menopause. Best Pract Res Clin Obstet Gynaecol 2009;23:25–32
   PubMed Web of Science ®Google Scholar
• Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010;85:87–94
   PubMed Web of Science ®Google Scholar
• Santoro N, Komi J. Prevalence and Impact of vaginal symptoms among postmenopausal women. J Sex Med 2009;6:2133–42
   PubMed Web of Science ®Google Scholar
• Nappi RE, Lachowsky M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas 2009;63:138–41
   PubMed Web of Science ®Google Scholar
• Palacios S. Managing urogenital atrophy. Maturitas 2009;63:315–18
   PubMed Web of Science ®Google Scholar
• 2011 EU Census [Internet]. Eurostat, the statistical office of the European Union; 2012. Available from: http://ec.europa.eu/eurostat/web/population-and-housing-census/census-data/2011-census
   Google Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) – results from an international survey. Climacteric 2012;15:36–44
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Panay N, Particco M, Krychman ML. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 2016;19:188–97
   PubMed Web of Science ®Google Scholar
• Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5:437–47
   PubMedGoogle Scholar
• Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 2014;17:3–9
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Krychman ML. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis. J Sex Med 2013;10:1567–74
   PubMed Web of Science ®Google Scholar
• Wyeth. REVEAL: REvealing Vaginal Effects At mid-Life. 2009
   Google Scholar
• North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14:355–69
   PubMed Web of Science ®Google Scholar
• Tan O, Bradshaw K, Carr BR. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review. Menopause 2012;19:109–17
   PubMed Web of Science ®Google Scholar
• Shulman LP, Portman DJ, Lee WC, et al. A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice. J Womens Health 2008;17:569–78
   PubMed Web of Science ®Google Scholar
• Nappi RE, Nijland EA. Women's perception of sexuality around the menopause: outcomes of a European telephone survey. Eur J Obstet Gynecol Reprod Biol 2008;137:10–16
   PubMed Web of Science ®Google Scholar
• Pfizer Pharmaceuticals, Inc. Healthy women survey [Internet]. 2012 [cited 2012 Aug 11]. Available from: www.perosnalmenopauseanswers.com/healthy-women-survey.aspx
   Google Scholar
• Simon J, Kingsberg S, Maamari R, Goldstein J, Nappi RE. The Partners' Survey; impact of vaginal discomfort and its treatment – insights, views, and attitudes of postmenopausal women and their partners. Abstract presented at 23rd Annual Meeting of the North American Menopause Society, Oct 3–6 2012, Orlando, Florida, USA
   Google Scholar
• Nappi RE, Mattsson L-Å, Lachowsky M, Maamari R, Giraldi A. The CLOSER survey: Impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe. Maturitas 2013;75:373–9
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med 2013;10:1790–9
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Panay N, Partico M. The REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: country-specific comparisons of postmenopausal women’s perceptions, experiences and needs. Maturitas 2016;91:81–90
   PubMed Web of Science ®Google Scholar
• Sutton KS, Boyer SC, Goldfinger C, Ezer P, Pukall CF. To lube or not to lube: experiences and perceptions of lubricant use in women with and without dyspareunia. J Sex Med 2012;9:240–50
   PubMed Web of Science ®Google Scholar
• Graziottin A. The challenge of sexual medicine for women: overcoming cultural and educational limits and gender biases. J Endocrinol Invest 2003;26(3 Suppl):139–42
   PubMedGoogle Scholar
• Bambra C, Pope D, Swami V, et al. Gender, health inequalities and welfare state regimes: a cross-national study of 13 European countries. J Epidemiol Community Health 2009;63:38–44
   PubMed Web of Science ®Google Scholar
• Maynou L, Saez M, Bacaria J, Lopez-Casasnovas G. Health inequalities in the European Union: an empirical analysis of the dynamics of regional differences. Eur J Health Econ HEPAC Health Econ Prev Care 2015;16:543–59
   PubMed Web of Science ®Google Scholar
• Reques L, Santos JM, Belza MJ, Martínez D, Regidor E. Inequalities in mortality at older ages decline with indicators of material wealth but persist with educational level. Eur J Public Health 2015;25:990–5
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Biglia N, Nappi RE, Schwenkhagen A, Palacios S. Characteristics of post-menopausal women with genitourinary syndrome of menopause: implications for vulvovaginal atrophy diagnosis and treatment selection. Maturitas 2015;81:462–9
   PubMed Web of Science ®Google Scholar
• Nappi RE, Particco M, Biglia N, et al. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: evidence from the European REVIVE survey. Maturitas 2016;91:74–80
   PubMed Web of Science ®Google Scholar
• Simon J, Komi J. Vulvovaginal atrophy (VVA) negatively impacts sexual function, psychosocial well-being, and partner relationships. In: Proceedings of the North American Menopause Society (NAMS). Dallas, TX, USA., 2007
   Google Scholar
• Palma F, Volpe A, Villa P, Cagnacci A, as the writing group of the AGATA study. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas 2016;83:40–4
   PubMed Web of Science ®Google Scholar
• Graziottin A. Libido: the biologic scenario. Maturitas 2000;34(Suppl 1):S9–16
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Pines A, International Menopause Society Writing Group, Archer DF, Baber RJ, Barlow D, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:242–55
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar